CDK9 and cancer: To determine the most likely transporter for which TAK-243 might serve as a substrate, we correlated publicly available mRNA expression data of these 12 transporters and the IC50 of TAK-243 across 30 cancer cell lines for which TAK-243 sensitivity has been reported (Supplemental Table 3) (2).